JP Morgan Chase
CLVS

JP Morgan Chase’s Clovis Oncology, Inc. CLVS Stock Holding History

JP Morgan Chase’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-109,800
Closed -$3.23M – 6024
2018
Q3 		$3.23M Buy
109,800
+8,100
+8% +$314K ﹤0.01% 3101
2018
Q2 		$4.62M Buy
+101,700
New +$4.95M ﹤0.01% 2746
2016
Q2 		– Sell
-566,400
Closed -$10.9M – 5035
2016
Q1 		$10.9M Buy
+566,400
New +$12M ﹤0.01% 1719
2015
Q2 		– Sell
-8,600
Closed -$638K – 4242
2015
Q1 		$638K Sell
8,600
-8,500
-50% -$600K ﹤0.01% 3435
2014
Q4 		$958K Sell
17,100
-19,100
-53% -$1M ﹤0.01% 3368
2014
Q3 		$1.64M Buy
+36,200
New +$1.51M ﹤0.01% 3052

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

JP Morgan Chase's CLVS Position: Q4 2022 in Review

JP Morgan Chase sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 10,183 shares — an estimated $12K sold.

JP Morgan Chase first reported a position in CLVS in Q2 2013 and held it in 38 quarters. The position peaked at $17.3M in Q2 2015. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • JP Morgan Chase reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 10,183 Clovis Oncology, Inc. shares in Q4 2022, an estimated $12K.
  • JP Morgan Chase first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 38 quarters.
  • JP Morgan Chase's Clovis Oncology, Inc. position peaked at $17.3M in Q2 2015.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.